GR851061B - - Google Patents
Info
- Publication number
- GR851061B GR851061B GR851061A GR850101061A GR851061B GR 851061 B GR851061 B GR 851061B GR 851061 A GR851061 A GR 851061A GR 850101061 A GR850101061 A GR 850101061A GR 851061 B GR851061 B GR 851061B
- Authority
- GR
- Greece
- Prior art keywords
- carbons
- trifluoromethyl
- fluoro
- chloro
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60735684A | 1984-05-04 | 1984-05-04 | |
| US06/714,012 US4569942A (en) | 1984-05-04 | 1985-03-22 | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR851061B true GR851061B (el) | 1985-11-25 |
Family
ID=27085497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR851061A GR851061B (el) | 1984-05-04 | 1985-05-02 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4569942A (el) |
| EP (2) | EP0164860B1 (el) |
| AT (2) | ATE44380T1 (el) |
| AU (1) | AU554290B2 (el) |
| CA (1) | CA1255658A (el) |
| DE (2) | DE3578173D1 (el) |
| DK (1) | DK162644C (el) |
| GR (1) | GR851061B (el) |
| IL (1) | IL75077A (el) |
| NZ (1) | NZ211938A (el) |
| PH (1) | PH22981A (el) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE41420T1 (de) * | 1984-02-07 | 1989-04-15 | Pfizer | 1,3-disubstituierte 2-oxindole und deren anwendung als analgetische und antiinflammatorische mittel. |
| US4678802A (en) * | 1985-07-09 | 1987-07-07 | Pfizer Inc. | 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents |
| US4791131A (en) * | 1985-07-09 | 1988-12-13 | Pfizer Inc. | Analgesic and antiinflammatory 1-acyl-2-oxindole-3-carboxamides |
| US4730004A (en) * | 1986-01-22 | 1988-03-08 | Pfizer Inc. | Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides |
| US5081131A (en) * | 1986-01-13 | 1992-01-14 | American Cyanamid Company | Omega-((hetero)alkyl)benz(cd)-indol-2-amines |
| DK288287A (da) * | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
| GB8623819D0 (en) * | 1986-10-03 | 1986-11-05 | Glaxo Group Ltd | Heterocyclic compounds |
| US5036099A (en) * | 1987-02-02 | 1991-07-30 | Pfizer Inc. | Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| GB8720693D0 (en) * | 1987-09-03 | 1987-10-07 | Glaxo Group Ltd | Chemical compounds |
| US4853409A (en) * | 1988-04-13 | 1989-08-01 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function |
| US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
| KR900701784A (ko) * | 1988-06-14 | 1990-12-04 | 스타이너 브이. 캔스타드 | 소염 활성을 갖는 헤테로비사이클릭 화합물 |
| US5182289A (en) * | 1988-06-14 | 1993-01-26 | Schering Corporation | Heterobicyclic compounds having antiinflammatory activity |
| HU215112B (hu) * | 1989-01-10 | 1998-12-28 | Pfizer Inc. | Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására |
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
| US5300655A (en) * | 1989-04-18 | 1994-04-05 | Pfizer Inc. | 2-carboxy-thiophene derivatives |
| US4952703A (en) * | 1989-05-25 | 1990-08-28 | Pfizer Inc. | Intermediates for making 2-oxindole-1-carboxamides |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| US5179119A (en) * | 1989-08-02 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Incorporated | 1,3-dihydro-1-(pyridinylamino)-2H-indol-1-ones and intermediates for the preparation thereof |
| IL95880A (en) * | 1989-10-13 | 1995-12-31 | Pfizer | Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis |
| WO1991009598A1 (en) * | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Azaoxindole derivatives |
| US5064851A (en) * | 1990-07-24 | 1991-11-12 | Pfizer Inc. | 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use |
| US5298522A (en) * | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| US5607959A (en) * | 1993-02-09 | 1997-03-04 | Pfizer Inc. | Oxindole 1-[N-(alkoxycarbonyl) ] carboxamides and 1-(N-carboxamido) carboxamides as antiinflammatory agents |
| BR9404929A (pt) * | 1993-04-09 | 1999-07-27 | Sony Corp | Processo e aparelho para codificação de imagens e suporte de gravação de imagens |
| US5359068A (en) * | 1993-06-28 | 1994-10-25 | Pfizer Inc. | Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| US5502072A (en) * | 1993-11-26 | 1996-03-26 | Pfizer Inc. | Substituted oxindoles |
| US5449788A (en) * | 1994-01-28 | 1995-09-12 | Catalytica, Inc. | Process for preparing 2-oxindole-1-carboxamides |
| US6469181B1 (en) | 1995-01-30 | 2002-10-22 | Catalytica, Inc. | Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles |
| US7186745B2 (en) | 2001-03-06 | 2007-03-06 | Astrazeneca Ab | Indolone derivatives having vascular damaging activity |
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| JP4497347B2 (ja) * | 2001-12-05 | 2010-07-07 | 塩野義製薬株式会社 | Ｈｉｖインテグラーゼ阻害活性を有する誘導体 |
| CA2484017A1 (en) * | 2002-04-22 | 2003-10-30 | Pfizer Products Inc. | Indol-2-ones as selective inhibitors of cyclooxygenase-2 |
| MY145694A (en) | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
| MY144968A (en) | 2005-04-11 | 2011-11-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| AR056317A1 (es) * | 2005-04-20 | 2007-10-03 | Xenon Pharmaceuticals Inc | Compuestos de oxindol y composicion farmaceutica |
| CA2608144C (en) | 2005-04-28 | 2012-11-13 | Proteus Biomedical, Inc. | Pharma-informatics system |
| MX2009002893A (es) | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
| TW200833695A (en) | 2006-10-12 | 2008-08-16 | Xenon Pharmaceuticals Inc | Use of spiro-oxindole compounds as therapeutic agents |
| SG10201703086VA (en) | 2008-10-17 | 2017-05-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their use as therapeutic agents |
| WO2010045197A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
| KR20190116576A (ko) | 2009-05-06 | 2019-10-14 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| MY165579A (en) | 2009-10-14 | 2018-04-05 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
| MA34083B1 (fr) | 2010-02-26 | 2013-03-05 | Xenon Pharmaceuticals Inc | Compositions pharmaceutques de composé spiro-oxindole pour administration topique et leur utilisation en tant qu'agents thérapeutiques |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
| US10537552B2 (en) | 2015-05-05 | 2020-01-21 | Carafe Drug Innovation, Llc | Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers |
| KR20220091537A (ko) * | 2019-11-01 | 2022-06-30 | 에프엠씨 코포레이션 | 2-아미노-5-클로로-n,3-디메틸벤즈아미드의 합성을 위한 효율적인 신규한 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL125443C (el) * | 1963-06-06 | |||
| GB1089071A (en) * | 1964-02-28 | 1967-11-01 | Merck & Co Inc | Indole derivatives |
| US3462450A (en) * | 1966-06-29 | 1969-08-19 | Merck & Co Inc | Chemical compounds |
| GB1158532A (en) * | 1967-01-05 | 1969-07-16 | Centre Nat Rech Scient | 2-Oxoindoline-3-Carboxylic Acids and Esters thereof |
| US3631177A (en) * | 1967-04-18 | 1971-12-28 | Smith Kline French Lab | 3-phenacyl-2-oxoindolines |
| US3519592A (en) * | 1967-04-18 | 1970-07-07 | Smithkline Corp | Indole compounds |
| BE714717A (el) * | 1967-05-12 | 1968-09-30 | ||
| FR7337M (el) * | 1968-01-11 | 1969-10-13 | ||
| BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
| US3749731A (en) * | 1971-07-08 | 1973-07-31 | Warner Lambert Co | 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide |
| US4012394A (en) * | 1973-02-16 | 1977-03-15 | Labaz | Indole derivatives |
| US3975531A (en) * | 1973-10-02 | 1976-08-17 | A. H. Robins Company, Incorporated | 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof |
| US4221716A (en) * | 1979-02-16 | 1980-09-09 | A. H. Robins Company, Inc. | Intermediate and process for the preparation of 7-acylindolin-2-ones |
-
1985
- 1985-03-22 US US06/714,012 patent/US4569942A/en not_active Expired - Lifetime
- 1985-04-30 AT AT85303044T patent/ATE44380T1/de not_active IP Right Cessation
- 1985-04-30 AT AT87200969T patent/ATE53576T1/de not_active IP Right Cessation
- 1985-04-30 EP EP85303044A patent/EP0164860B1/en not_active Expired
- 1985-04-30 DE DE8787200969T patent/DE3578173D1/de not_active Expired - Lifetime
- 1985-04-30 DE DE8585303044T patent/DE3571320D1/de not_active Expired
- 1985-04-30 EP EP87200969A patent/EP0244918B1/en not_active Expired - Lifetime
- 1985-05-01 NZ NZ211938A patent/NZ211938A/xx unknown
- 1985-05-02 IL IL75077A patent/IL75077A/xx not_active IP Right Cessation
- 1985-05-02 CA CA000480573A patent/CA1255658A/en not_active Expired
- 1985-05-02 DK DK197685A patent/DK162644C/da not_active IP Right Cessation
- 1985-05-02 GR GR851061A patent/GR851061B/el unknown
- 1985-05-03 AU AU41938/85A patent/AU554290B2/en not_active Expired
- 1985-05-03 PH PH32231A patent/PH22981A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0244918B1 (en) | 1990-06-13 |
| IL75077A (en) | 1988-03-31 |
| DE3571320D1 (en) | 1989-08-10 |
| PH22981A (en) | 1989-02-24 |
| ATE53576T1 (de) | 1990-06-15 |
| NZ211938A (en) | 1988-08-30 |
| US4569942A (en) | 1986-02-11 |
| AU4193885A (en) | 1985-11-07 |
| AU554290B2 (en) | 1986-08-14 |
| EP0244918A3 (en) | 1989-02-22 |
| EP0244918A2 (en) | 1987-11-11 |
| DK197685D0 (da) | 1985-05-02 |
| IL75077A0 (en) | 1985-09-29 |
| DK162644C (da) | 1992-04-13 |
| EP0164860A1 (en) | 1985-12-18 |
| EP0164860B1 (en) | 1989-07-05 |
| DK162644B (da) | 1991-11-25 |
| ATE44380T1 (de) | 1989-07-15 |
| DK197685A (da) | 1985-11-05 |
| DE3578173D1 (de) | 1990-07-19 |
| CA1255658A (en) | 1989-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR851061B (el) | ||
| GR852493B (el) | ||
| IE791099L (en) | Histamine h2 antagonists | |
| EP0276500A3 (en) | 2-oxindole intermediates | |
| AU569606B2 (en) | 1-(4-(benzothia- or -oxazol-2-ylthio-or-2-yloxy) phenyl)-1, 3,5-triazine-2,4,6(1h 3h, 5h)-triones | |
| EG17752A (en) | Benzoylurea derivatives | |
| EP0190712A3 (en) | Pyrrole-3-carboxylate cardiotonic agents | |
| AP8800109A0 (en) | "Heterocyclic insecticides". | |
| ES8601152A1 (es) | Procedimiento para la obtencion de derivados de acido barbi-turico | |
| ES2163401T3 (es) | 5,8-dihidrodiazaantracenos con actividad antitumoral. | |
| GB8528234D0 (en) | Heterocyclic compounds | |
| AU630839B2 (en) | Sulfinyl imidazole derivatives and antiulcer agents containing the same | |
| AU557979B2 (en) | Thiazolidin-and hydrothiazin-derivatives | |
| ES8505804A1 (es) | Procedimiento para preparar derivados fluorados de pirrolidona con actividad herbicida | |
| GB8627301D0 (en) | Heterocyclic compounds | |
| ES2061406A1 (es) | Nuevos derivados de la 2-(quinolina) con actividad farmacologica. | |
| ATE16280T1 (de) | Salze von mikrobiziden naphthyridin- bzw. chinolinverbindungen und ihre herstellung. |